A
American Critical Minerals Corp
CNSX:KCLI
American Critical Minerals Corp
CNSX:KCLI
Price:
0.22
CAD
2.33%
Market Closed
Market Cap:
CA$18.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
American Critical Minerals Corp
CNSX:KCLI
|
CA |
|
M
|
Mirae Asset Global REIT Co Ltd
KRX:396690
|
KR |
|
E
|
Endurance Gold Corp
OTC:ENDGF
|
CA |
|
Bioharvest Sciences Inc
OTC:CNVCF
|
CA |
|
F
|
Fidia SpA
F:FIC
|
IT |
|
F
|
Focusrite PLC
OTC:FOCIF
|
UK |
|
C
|
Capgemini SE
LSE:0HAZ
|
FR |
|
I
|
Iberdrola SA
DUS:IBE1
|
ES |
|
American Healthcare REIT Inc
NYSE:AHRT
|
US |
|
O
|
Organization of Football Prognostics SA
ATHEX:ALWN
|
GR |
|
E.Bon Holdings Ltd
HKEX:599
|
HK |
Balance Sheet
Balance Sheet Decomposition
American Critical Minerals Corp
American Critical Minerals Corp
Balance Sheet Decomposition is not available for
American Critical Minerals Corp
American Critical Minerals Corp
Balance Sheet
American Critical Minerals Corp
American Critical Minerals Corp
Currency: CAD
| Jul-2020 | Jul-2021 | Jul-2022 | Jul-2023 | Jul-2024 | Jul-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
1
|
0
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+785%
|
1
+207%
|
1
-16%
|
1
+18%
|
2
+100%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-67%
|
0
+78%
|
0
+32%
|
0
+234%
|
0
-17%
|
|
| Equity | |||||||
| Common Stock |
9
|
10
|
11
|
12
|
12
|
14
|
|
| Retained Earnings |
9
|
10
|
10
|
11
|
12
|
13
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
1
+222%
|
1
-19%
|
1
-5%
|
2
+143%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+785%
|
1
+207%
|
1
-16%
|
1
+18%
|
2
+100%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
13
|
19
|
28
|
36
|
41
|
56
|
|
Switch to:
Switch to:
See Also
Discover More
